SS
OCUL icon

Simplicity Solutions’s Ocular Therapeutix OCUL Stock Holding History

Simplicity Solutions’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$201K Buy
+44,987
New +$133K 0.01% 977

Other funds holding OCUL

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Simplicity Solutions's OCUL Position: Q4 2023 in Review

Simplicity Solutions opened a new position in Ocular Therapeutix (OCUL) in Q4 2023: 44,987 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #977 among its holdings.

118 funds tracked by Wall St. Rank hold OCUL as of Q4 2023.

  • Simplicity Solutions held 44,987 shares of Ocular Therapeutix worth $201K as of Q4 2023.
  • Ocular Therapeutix was a new Simplicity Solutions position in Q4 2023.
  • Ocular Therapeutix made up 0.01% of Simplicity Solutions's portfolio in Q4 2023, its #977 holding.
  • 118 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.